The Permeability Transition Pore Complex: A Target for Apoptosis Regulation by Caspases and Bcl-2–related Proteins
暂无分享,去创建一个
G. Kroemer | John Calvin Reed | C. Brenner | D. Brdiczka | N. Zamzami | Z. Xie | I. Marzo | S. Susin | R. Rémy | G. Beutner
[1] L. Scorrano,et al. The mitochondrial permeability transition , 2022, BioFactors.
[2] E. Cheng,et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. , 1997, Science.
[3] M. V. Heiden,et al. Bcl-xL Regulates the Membrane Potential and Volume Homeostasis of Mitochondria , 1997, Cell.
[4] A. Koretsky,et al. The role of creatine kinase in inhibition of mitochondrial permeability transition , 1997, FEBS letters.
[5] Shahrooz Rabizadeh,et al. Establishment of a Cell-Free System of Neuronal Apoptosis: Comparison of Premitochondrial, Mitochondrial, and Postmitochondrial Phases , 1997, The Journal of Neuroscience.
[6] Xiaodong Wang,et al. Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3 , 1997, Cell.
[7] G. Kroemer. The proto-oncogene Bcl-2 and its role in regulating apoptosis , 1997, Nature Medicine.
[8] K. Bhalla,et al. Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. , 1997, Cancer research.
[9] F Gambale,et al. Inhibition of Bax channel-forming activity by Bcl-2. , 1997, Science.
[10] G. Kroemer,et al. The Central Executioner of Apoptosis: Multiple Connections between Protease Activation and Mitochondria in Fas/APO-1/CD95- and Ceramide-induced Apoptosis , 1997, The Journal of experimental medicine.
[11] G. Kroemer,et al. Nitric oxide induces apoptosis via triggering mitochondrial permeability transition , 1997, FEBS letters.
[12] J. Mazat,et al. Mitochondria Are Excitable Organelles Capable of Generating and Conveying Electrical and Calcium Signals , 1997, Cell.
[13] R. Weichselbaum,et al. Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[14] John Calvin Reed. Double identity for proteins of the Bcl-2 family , 1997, Nature.
[15] J C Reed,et al. Channel formation by antiapoptotic protein Bcl-2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[16] C. Thompson,et al. Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[17] B. Herman,et al. Mitochondrial permeability transition in hepatocytes induced by t-BuOOH: NAD(P)H and reactive oxygen species. , 1997, The American journal of physiology.
[18] C. Piantadosi,et al. Release of cytochrome c from liver mitochondria during permeability transition. , 1997, Biochemical and biophysical research communications.
[19] M. Grütter,et al. Structure of Recombinant Human CPP32 in Complex with the Tetrapeptide Acetyl-Asp-Val-Ala-Asp Fluoromethyl Ketone* , 1997, The Journal of Biological Chemistry.
[20] Dean P. Jones,et al. Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.
[21] D. Green,et al. The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.
[22] A. Halestrap,et al. Oxidative Stress, Thiol Reagents, and Membrane Potential Modulate the Mitochondrial Permeability Transition by Affecting Nucleotide Binding to the Adenine Nucleotide Translocase* , 1997, The Journal of Biological Chemistry.
[23] A. Strasser,et al. Bcl-2, Bcl-xL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death , 1997, Oncogene.
[24] Andy J. Minn,et al. Bcl-xL forms an ion channel in synthetic lipid membranes , 1997, Nature.
[25] G. Kroemer,et al. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. , 1997, Cancer research.
[26] J. Xiang,et al. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] Keisuke Kuida,et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice , 1996, Nature.
[28] J. Farber,et al. The Cytotoxicity of Tumor Necrosis Factor Depends on Induction of the Mitochondrial Permeability Transition* , 1996, The Journal of Biological Chemistry.
[29] W. Welte,et al. Complexes between kinases, mitochondrial porin and adenylate translocator in rat brain resemble the permeability transition pore , 1996, FEBS letters.
[30] G. Kroemer,et al. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease , 1996, The Journal of experimental medicine.
[31] A. F. Schinder,et al. Mitochondrial Dysfunction Is a Primary Event in Glutamate Neurotoxicity , 1996, The Journal of Neuroscience.
[32] I. Reynolds,et al. Mitochondrial Depolarization in Glutamate-Stimulated Neurons: An Early Signal Specific to Excitotoxin Exposure , 1996, The Journal of Neuroscience.
[33] E. Wang,et al. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[34] J. Lemasters,et al. The mitochondrial permeability transition: a new pathophysiological mechanism for Reye's syndrome and toxic liver injury. , 1996, The Journal of pharmacology and experimental therapeutics.
[35] G. Kroemer,et al. Mitochondrial permeability transition is a central coordinating event of apoptosis , 1996, The Journal of experimental medicine.
[36] S. Srinivasula,et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[37] Xiaodong Wang,et al. Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.
[38] Y. Tsujimoto,et al. Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. , 1996, Oncogene.
[39] M. Klingenberg,et al. Mitochondrial ADP/ATP carrier can be reversibly converted into a large channel by Ca2+. , 1996, Biochemistry.
[40] G. Evan,et al. A License to Kill , 1996, Cell.
[41] R. Meadows,et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death , 1996, Nature.
[42] S. Nagata,et al. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis , 1996, Nature.
[43] Paolo Bernardi,et al. The permeability transition pore as a mitochondrial calcium release channel: A critical appraisal , 1996, Journal of bioenergetics and biomembranes.
[44] G. Kroemer,et al. Mitochondrial control of nuclear apoptosis , 1996, The Journal of experimental medicine.
[45] P. Bernardi,et al. Interactions of Cyclophilin with the Mitochondrial Inner Membrane and Regulation of the Permeability Transition Pore, a Cyclosporin A-sensitive Channel (*) , 1996, The Journal of Biological Chemistry.
[46] B. Viollet,et al. Bcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice , 1996, Nature Medicine.
[47] A. Strasser,et al. Bcl‐2 and Fas/APO‐1 regulate distinct pathways to lymphocyte apoptosis. , 1995, The EMBO journal.
[48] M. Moreno,et al. Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma. , 1995, Journal of immunology.
[49] Seamus J. Martin,et al. Protease activation during apoptosis: Death by a thousand cuts? , 1995, Cell.
[50] G. Kroemer,et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death , 1995, The Journal of experimental medicine.
[51] G. Kroemer,et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo , 1995, The Journal of experimental medicine.
[52] J C Reed,et al. Bcl-2 blocks degranulation but not fas-based cell-mediated cytotoxicity. , 1995, Journal of immunology.
[53] Z. Oltvai,et al. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax , 1994, Nature.
[54] A. Halestrap,et al. Protection by Cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. , 1993, Journal of molecular and cellular cardiology.
[55] Junying Yuan,et al. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3 , 1993, Cell.
[56] P. Pedersen,et al. Hexokinase receptors: Preferential enzyme binding in normal cells to nonmitochondrial sites and in transformed cells to mitochondrial sites , 1992, Journal of bioenergetics and biomembranes.
[57] J. Huet,et al. Variation of the polypeptide composition of mitochondria isolated from different potato tissues. , 1992, Plant physiology.
[58] E. McCabe,et al. Targeting of hexokinase 1 to liver and hepatoma mitochondria. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[59] R. New,et al. Liposomes : a practical approach , 1990 .
[60] J. Rigaud,et al. Mechanisms of membrane protein insertion into liposomes during reconstitution procedures involving the use of detergents. 2. Incorporation of the light-driven proton pump bacteriorhodopsin. , 1988, Biochemistry.
[61] H. Knull,et al. Effects of energy metabolism on in vivo distribution of hexokinase in brain. , 1973, Journal of Biological Chemistry.